Fluvoxamine maleate and Lipidil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 5 people who take Fluvoxamine maleate and Lipidil. Common interactions include gait disturbance among females, and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people who take Fluvoxamine maleate and Lipidil have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 24, 2023

5 people who take Fluvoxamine maleate and Lipidil together, and have interactions are studied.


What is Fluvoxamine maleate?

Fluvoxamine maleate has active ingredients of fluvoxamine maleate. It is used in obsessive-compulsive disorder. Currently, eHealthMe is studying from 3,652 Fluvoxamine maleate users.

What is Lipidil?

Lipidil has active ingredients of fenofibrate. It is used in high blood cholesterol. Currently, eHealthMe is studying from 2,638 Lipidil users.

Number of Fluvoxamine maleate and Lipidil reports submitted per year:

Fluvoxamine maleate and Lipidil drug interactions.

Common Fluvoxamine Maleate and Lipidil drug interactions by gender *:

female:

  1. Gait disturbance
  2. Muscle spasms
  3. Myalgia
  4. Pain in extremity

male:

  1. Cardiac arrest
  2. Myocardial ischaemia
  3. Bronchitis
  4. Bronchitis chemical
  5. Cellulitis
  6. Diabetes mellitus
  7. Glossodynia
  8. Hepatic steatosis
  9. Hypertension
  10. Renal failure chronic

Common Fluvoxamine Maleate and Lipidil drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Gait disturbance
  2. Muscle spasms
  3. Myalgia
  4. Pain in extremity
  5. Cardiac arrest
  6. Myocardial ischaemia

* Approximation only. Some reports may have incomplete information.

Do you take Fluvoxamine maleate and Lipidil?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Fluvoxamine maleate side effects:

Browse all side effects of Fluvoxamine maleate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lipidil side effects:

Browse all side effects of Lipidil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fluvoxamine maleate interactions:

Browse all interactions between Fluvoxamine maleate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lipidil interactions:

Browse all interactions between Lipidil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluvoxamine maleate and fenofibrate (the active ingredients of Fluvoxamine maleate and Lipidil, respectively), and Fluvoxamine maleate and Lipidil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Fluvoxamine maleate and Lipidil.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: